Relativity Announces Skadden as the Next Participant in Advanced Access Program for Relativity claiR
CHICAGO, Sept. 9, 2026 /PRNewswire/ -- Relativity, a legal data intelligence company, today announced that global law firm Skadden, Arps, Slate, Meagher & Flom LLP will join the Advanced Access program for Relativity claiR, a new conversational...
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market...
![Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial](http://prnewswire.vietreader.com/thumb/190x300/2018-01/1515317794_image.png)
Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial
LONDON, Sept. 9, 2026 /PRNewswire/ -- Full-Life Technologies ("Full-Life", the "Company"), a privately held, fully integrated, clinical-stage actinium-based global radiopharmaceutical company, today announced that the U.S. Food and Drug...
SuperX Announces an Update on the Progress of Share Repurchases Program, to Demonstrate Confidence in Long-Term Growth Value
SINGAPORE, Sept. 9, 2026 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX) ("SuperX" or the "Company"), a Nasdaq-listed full-stack AI infrastructure solutions provider, today announced an update on the progress of its share repurchase...
Cheche Group Announces Proposed Strategic Investment in Global Residential Energy Storage Business, Advancing Green Mobility to Green Energy Strategy
Proposed strategic investment in Long Way Fortune's residential solar-plus-storage business, with potential to increase ownership over time, supporting Cheche's new "Green Mobility + Green Energy" two-pillar strategy BEIJING, Sept. 9, 2026...
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
Multicenter study to evaluate paxalisib plus gemcitabine for children and young adults with recurrent or progressive AT/RT, where no approved therapies currently exist SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA)...
Robo.ai Announces Proposed Establishment of Alif Maritec, a Marine Security and Intelligent Maritime Infrastructure Company
Wholly owned subsidiary of Alif Holding to focus on maritime protection, smart ports, underwater intelligence and critical infrastructure protection; Dr. Jasem Al-Mansory expected to serve as Chairman ABU DHABI, UAE, Sept. 9, 2026 /PRNewswire/ --...
Youlife Group, Inc. Announces Participation in the Skyline Signature Series Webinar
SHANGHAI, Sept. 9, 2026 /PRNewswire/ -- Youlife Group Inc. ("Youlife" or the "Company") (NASDAQ: YOUL), a leading blue-collar lifetime service provider in China, is pleased to announce that Stanley Yang, Chief Strategy Officer, will be delivering a...
Thoma Bravo Announces Strategic Growth Investment in Tanda
Investment to accelerate Tanda's product innovation and global growth BRISBANE, Australia and SAN FRANCISCO, Sept. 9, 2026 /PRNewswire/ -- Thoma Bravo, the world's largest software-focused investment firm, today announced a strategic growth...
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
NEW YORK and SUZHOU, China, Sept. 8, 2026 /PRNewswire/ -- Accro Bioscience (Suzhou) Limited ("Accro") today announced that Shanghai Fosun Pharmaceutical Industrial Development Company Limited ("Fosun Pharma Industrial"), a subsidiary of its partner...